This page shows the latest Novartis Pharma news and features for those working in and with pharma, biotech and healthcare.
Outside the US, Swiss pharma company Novartis markets the drug as Jakavi. ... Last year, Novartis and Inctye also attempted to extend Jakafi’s reach into COVID-19, with a phase 3 study investigating whether the drug could be used as a treatment for
Swiss pharma company Novartis has entered into an agreement with the Bill &Melinda Gates Foundation for the discovery and development of an ‘accessible’ gene therapy for sickle cell disease (SCD). ... added. As part of the agreement strategy,
Novartis will help manufacture Pfizer/BioNTech's vaccine and Bayer will do the same for CureVac's vaccine. ... Swiss pharma company Novartis has reached an agreement with Pfizer and BioNTech to provide manufacturing capacity for their COVID-19 vaccine.
Novartis also said that pandemic-associated restrictions affected its Sandoz retail business in certain locations. ... Novartis delivered a solid performance in 2020 across our strategic priorities, despite the challenges of COVID-19.
Swiss pharma company Novartis has received a breakthrough therapy designation (BTD) for its experimental medication iptacopan for the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH). ... Alexion’s other long-acting C5 inhibitor, Ultomiris
Investigational drug beat Pfizer's Bosulif in phase 3 study. Novartis’ investigational treatment asciminib induced a superior molecular response rate (MMR) compared to Pfizer’s Bosulif in chronic myeloid leukaemia patients ... Novartis has been at
More from news
Approximately 6 fully matching, plus 553 partially matching documents found.
and. CAR-T therapies. Gilead’s acquisition of Kite Pharma and Bristol-Myers Squibb’s acquisition of Juno Therapeutics, as well as the merger and acquisition agreements between Novartis/Spark and ... Novartis/AveXis, are all recent examples of larger
The Swiss flagship pharma and biotech companies such as Roche, Novartis, Actelion and ACImmune tend to garner a lot of attention, but in their small home country there is a rich ... A strong pharma and biotech history and presence. Among the top five big
It’s too early to say what style Hahn will bring to the role and its impact on the pharma sector. ... drugmaker Sanofi on 1 September last year from a prior role as head of pharma at Novartis.
1 trial of its lead candidate ARV-110 in prostate cancer earlier this year, ahead of rival biotechs such as C4 Therapeutics and Kymera Therapeutics as well as big pharma firms ... That’s not dampening enthusiasm for the emerging field, however, and by
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020. ... BMS will become the fourth largest pharma firm by sales – behind Pfizer, Novartis and Roche – and the addition of new Celgene brands like
More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.
Acceleron . Acceleron Pharma has poached Jay Backstrom (pictured right) from Celgene, where he worked as chief medical officer. ... He has also served in various executive leadership roles at Novartis Pharma and Novartis Oncology, and he began his
She spent time at Novartis representing the interests of pharma, and also worked at start-up brand Headspace.
Welteverden, who was previously head of business services for Syngenta, will join Novartis’ Basel base in Switzerland. ... Klinger initially joined Novartis back in 2011 as general counsel, North America for its biopharmaceutical arm Sandoz.
She succeeds Bruno Strigini who retires. Novartis has appointed Elizabeth Barrett to head up its oncology franchise based at the group’s headquarters in Switzerland. ... Her long-time commercial pharma industry experience, marketing skills and
The head of Novartis Oncology Bruno Strigini is set to step down and retire from the pharmaceutical industry. ... Novartis CEO Joseph Jimenez said: "I'd like to thank Bruno Strigini for his contributions and achievements.
More from appointments
Approximately 0 fully matching, plus 32 partially matching documents found.
With an actionable reach of over a million HCPs globally, EPG Health provides customers (including most of the top 20 pharma companies) with an integrated toolset to:. ... Novartis, Orphan Europe, Philips, Pfizer, Roche, Sanofi, Takeda, UCB, Uriach,
Johnson &Johnson and Pfizer are two of the largest pharma companies in the world by revenue but both have numerous biological therapies. ... This approach is particularly apparent in some of the recent examples of technology pioneered by biotech
Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines. ... The last few years have seen influential scientific advances, resulting in subtle shifts in how pharma tackles disease treatment.
We spoke to patients, academics, Pharma, not-for-profit and industry professionals to find out the value of the patient voice. ... help deliver it How Pharma should evolve its practices to drive patient activation.
Gareth has over 20 years’ experience in senior roles in a number of pharma companies, most recently at Novartis, where he spent seven years in various roles, including Brand Lead Opthalmology, ... biggest pharma companies.” Gareth will be based at
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...